Mediar Therapeutics logo

Mediar Therapeutics

Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression.

55 employees · est. 2019 · Boston, United States

VS
Vanqua Bio logo

Vanqua Bio

Vanquishing Neurodegeneration.

32 employees · est. 2019 · Chicago, United States

Mediar Therapeutics is the larger of the two.

Side-by-Side Comparison

Mediar Therapeutics Vanqua Bio
Founded
2019 2019
Headquarters
Boston, United States Chicago, United States
Employees
55 larger 32
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Series A Series Unknown
Total Funding
$85.00M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech Company, Fibrosis Treatment, Preclinical Stage, Novel Targets, Blood Biomarkers, Disease Progression, Clinical Development Not tracked yet
Website
mediartx.com vanquabio.com
Mediar Therapeutics logo

About Mediar Therapeutics

Mediar Therapeutics is a preclinical stage biotech company with a mission to develop innovative treatments to halt or even reverse fibrosis. The company takes a pioneering approach by targeting the fibrotic mediators driving disease progression. Founded in 2019, Mediar is deeply rooted in its unders...

Vanqua Bio logo

About Vanqua Bio

Vanqua Bio is helping usher in a new era of hope for the millions of people living with neurodegenerative diseases. Our unique drug-development approach is designed to overcome longstanding challenges in the neuroscience field by capitalizing on the power of human genetics to identify genes that cau...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Mediar Therapeutics and Vanqua Bio — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Mediar Therapeutics and Vanqua Bio — by email.

Frequently Asked Questions

Mediar Therapeutics — Mediar Therapeutics is a clinical stage company advancing first-in-class therapies to halt fibrosis progression.. Vanqua Bio — Vanquishing Neurodegeneration. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mediar Therapeutics has raised $85.00M while Vanqua Bio has raised undisclosed funding.
Mediar Therapeutics and Vanqua Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mediar Therapeutics with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy